Hospital
Tulare Local Health Care District
Tulare Local Health Care District was paid $984K by Medicaid between Oct 2018 and May 2019, across 88 billing codes. Its largest line is 0450, Emergency room services — 41% of everything it billed.
33Billing provider infoTULARE LOCAL HEALTH CARE DISTRICT
TULARE, CA 93274
TULARE, CA 93274
33aNPI1306840723assigned 06/13/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$984K
24GClaims29,930
24DCodes billed88
24AFirst – last monthOct 2018 – May 2019
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#273 of 410
Median peer was paid$6.90M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,443 | $475K | |
| 2019 | 15,487 | $509K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 41% | 4,720 | 4,064 | $407K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.0% | 215 | 204 | $50K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.9% | 662 | 586 | $49K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.6% | 611 | 555 | $46K |
| 99199 | Unlisted special service, procedure or report | 3.9% | 365 | 350 | $39K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.8% | 371 | 325 | $28K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 204 | 193 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.7% | 304 | 264 | $26K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.2% | 673 | 591 | $21K |
| 80053 | Comprehensive metabolic panel | 1.8% | 1,597 | 1,394 | $18K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.8% | 143 | 137 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 581 | 495 | $16K |
76 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 685 | $15K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 1.5% | 1,103 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 1,846 | $14K |
| J3490 | Unclassified drugs | 1.4% | 2,026 | $13K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.0% | 103 | $10K |
| 99283 | Emergency room visit (moderate) | 1.0% | 100 | $10K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 133 | $9K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 757 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 634 | $7K |
| 83880 | <1% | 244 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 291 | $6K |
| 99284 | Emergency room visit (serious) | <1% | 70 | $6K |
| 99285 | Emergency room visit (most serious) | <1% | 116 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 726 | $5K |
| 84484 | <1% | 568 | $5K | |
| 81001 | <1% | 1,464 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 350 | $5K |
| 83690 | <1% | 623 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 566 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 542 | $4K |
| 80306 | <1% | 219 | $4K | |
| 87040 | <1% | 280 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 62 | $3K |
| 96376 | <1% | 90 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 320 | $3K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 76 | $3K |
| Q9962 | High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml | <1% | 214 | $3K |
| 76801 | <1% | 63 | $3K | |
| 83605 | <1% | 273 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 469 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $3K |
| 81025 | <1% | 608 | $3K | |
| 29125 | <1% | 26 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 267 | $2K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 33 | $2K |
| 73610 | <1% | 72 | $2K | |
| 84702 | <1% | 129 | $2K | |
| 73630 | <1% | 65 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 195 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 227 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 44 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 33 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 289 | $2K |
| 73130 | <1% | 54 | $2K | |
| 0270 | <1% | 108 | $1K | |
| 73110 | <1% | 37 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 131 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 27 | $1K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 166 | $1K |
| 73030 | <1% | 51 | $1K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12 | $982.77 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 160 | $933.69 |
| 87420 | <1% | 92 | $894.00 | |
| 87070 | <1% | 87 | $841.90 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 131 | $839.21 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 111 | $709.27 |
| 74018 | <1% | 33 | $603.96 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 43 | $531.09 |
| 73562 | <1% | 18 | $510.88 | |
| 84703 | <1% | 102 | $503.42 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 14 | $467.40 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $460.38 |
| 86901 | <1% | 131 | $454.21 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 66 | $449.54 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 62 | $421.61 |
| 36415 | Collection of venous blood by venipuncture | <1% | 299 | $405.41 |
| 85379 | <1% | 34 | $377.48 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 40 | $369.17 |
| 90714 | <1% | 12 | $348.79 | |
| 86900 | <1% | 127 | $336.74 | |
| 73590 | <1% | 14 | $309.21 | |
| 86140 | <1% | 50 | $288.52 | |
| 85610 | <1% | 73 | $267.20 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 13 | $263.90 |
| 85730 | <1% | 29 | $163.35 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 131 | $12.64 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWALKER, PAUL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Associates in Pediatric Care, P.C. | Norfolk, VA | $1.71M |
| The Children and Adult Counseling Center LLC | Norfolk, VA | $1.12M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.